Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Distributors' Sustainability Efforts: Protecting Patients and the Planet
A new report estimates that the overall health costs of climate change already exceed $820 billion each year. The healthcare sector alone is responsible for nearly 5 percent of worldwide greenhouse gas emissions. According to a December 2020 Health Affairs study, “health damages stemming from U.S. [healthcare] pollution in 2013 [are] on the same order of magnitude as deaths from preventable medical errors.” Unfortunately, many of the most vulnerable communities are impacted by the harmful effects of climate change.
Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.
Chip Davis: Distributors are “Answering the Call” In Response to COVID-19
During one of the most ambitious immunization campaigns in our history, HDA President and CEO Chip Davis reinforced the distribution industry’s commitment to “answering the call” when assisting the federal, state and local governments as part of a nationwide vaccination push.
HDA Announces Chad Gielen and Kirk Kaminsky To Lead Board of Directors
HDA announced Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., as Chairman of the HDA Board of Directors. Kirk Kaminsky, President, McKesson U.S. Pharmaceutical, will serve as Vice Chairman